Home › Brands › Curaleaf
⚐ Flag an error How this page was made
Also known as: Curaleaf Holdings Inc. · CURA · CURLF

Curaleaf

Multi-state cannabis operator and publicly traded parent of Select and Grassroots brands.

Automated fact-check pass
7 cited sources
Published
Last reviewed
How this page was made
↯ The honest take

Curaleaf is large, publicly traded, and present in many US cannabis markets — but size does not guarantee product safety or quality. The company has faced FDA warnings for unsubstantiated health claims and a serious mislabeling incident in Oregon. If you buy a Curaleaf, Select, or Grassroots product, verify the current state license, check the lab test for that specific batch, and treat the brand name as a starting point, not a safety guarantee.

What it is

Curaleaf Holdings Inc. is a vertically integrated cannabis company headquartered in New York that cultivates, processes, and sells cannabis and hemp-derived products through its own dispensaries and wholesale channels [1][2]. The company operates under state-by-state licenses in the United States and, through subsidiaries, in parts of Europe [2]. It trades publicly on the Toronto Stock Exchange under the ticker CURA and over-the-counter in the US as CURLF [1].

Within the cannabis industry, Curaleaf is categorized as a multi-state operator, or MSO—a company that holds licenses and runs operations in several US states simultaneously. Industry trade press has described it as among the largest MSOs by revenue, though specific rankings shift quarter to quarter and should be checked against current financial filings rather than older articles.

Ownership and structure

Curaleaf Holdings is a publicly traded parent company; it is not privately owned by a single individual. Executive chairman Boris Jordan has historically been the largest shareholder according to company disclosures [1][2]. The company was assembled through a series of mergers and acquisitions, most notably the 2020 acquisition of Grassroots Cannabis, which expanded its footprint into the Midwest, and the 2019–2020 acquisition of Cura Partners (owner of the Select brand), a vape and concentrate brand originally founded in Oregon [3][4].

These acquisitions explain why product labels at Curaleaf-affiliated dispensaries may read 'Select' or 'Grassroots' rather than 'Curaleaf'—they are house brands under the same corporate parent [3][4]. Curaleaf also operates Curaleaf International for medical cannabis markets in Europe.

Market and category focus

Curaleaf's business spans cultivation, manufacturing (edibles, vapes, concentrates, tinctures, topicals), retail dispensaries, and wholesale distribution to other licensed retailers [2]. The Select brand is primarily known for vape cartridges and concentrates; Grassroots is known for flower and pre-rolls [3][4]. Curaleaf-branded products span most major form factors [2].

The company has also expanded into international medical cannabis markets, including Germany and the United Kingdom, through Curaleaf International [2]. In 2024, Curaleaf announced it would pursue a listing on a US exchange contingent on federal regulatory changes—readers should treat any such announcements as conditional until confirmed by filings.

Large cannabis operators face proportionally more regulatory scrutiny than smaller ones. Curaleaf has faced several documented public enforcement actions:

FDA warning letter (2019). The US Food and Drug Administration issued Curaleaf a warning letter for making unsubstantiated health claims about CBD products, including claims related to cancer, Alzheimer's disease, opioid withdrawal, and pet anxiety [5]. The company removed the offending claims Strong evidence[5].

Oregon mislabeling and recall (2021). Curaleaf's Select-branded Oregon operation was involved in a recall after THC tinctures were reportedly mislabeled and sold as CBD, leading to hospitalizations [6]. The Oregon Liquor and Cannabis Commission and regional journalism outlets documented the incident and subsequent litigation Strong evidence[6].

Securities litigation. Curaleaf, like most large public cannabis companies, has been named in shareholder lawsuits. Current status should be checked in the company's most recent SEC and Canadian securities filings rather than this article.

These incidents illustrate why 'established brand' should not be conflated with 'product safety.' Regulatory history matters, but it should be weighed alongside current compliance—check current license status with the relevant state regulator.

Curaleaf-affiliated dispensaries and products are available only within state-licensed cannabis markets where the company holds active licenses. Because of US federal prohibition, cannabis products cannot legally cross state lines, so a 'Select' cartridge sold in Massachusetts and one sold in Arizona are separate state-licensed products manufactured under separate state programs, even though they share branding [2][7].

This means:

Licenses can be suspended, transferred, or revoked. A dispensary operating today under the Curaleaf name may have a different operator within months.

What to verify before relying on claims

Before trusting any specific claim about a Curaleaf, Select, or Grassroots product, verify:

  1. Current license status with the state cannabis regulator (e.g., Massachusetts CCC, Florida OMMU, New York OCM). Licenses can change hands or be revoked.
  2. Certificate of analysis (COA) for the specific batch—potency and contaminant testing varies by state lab and by testing program.
  3. Recall notices from state regulators and the company itself. Check the state regulator's public recall database.
  4. Current corporate structure, since MSOs frequently divest or acquire assets in specific states.
  5. Marketing claims about wellness or medical benefits, which the FDA has previously cited Curaleaf for making without adequate evidence [5].

This profile was last checked in October 2026. Corporate structure, brand ownership, and licensing change frequently in the cannabis industry; treat any specific claim here as a starting point for your own verification, not a final answer.

Sources

  1. Government Curaleaf Holdings Inc. – Issuer profile, SEDAR+ (Canadian Securities Administrators).
  2. Reported Curaleaf Holdings Inc. company profile, Reuters Markets.
  3. Reported Williams S. 'Curaleaf closes acquisition of Grassroots,' MJBizDaily, July 2020.
  4. Reported Schroyer J. 'Curaleaf to acquire Select brand owner Cura Partners,' MJBizDaily, 2020.
  5. Government US Food and Drug Administration. Warning Letter to Curaleaf Inc., July 22, 2019.
  6. Reported Oregon cannabis company recalls tincture after customers hospitalized. Oregonian / Associated Press, September 2021.
  7. Government US Drug Enforcement Administration. Drug Scheduling – Marijuana (Schedule I).

How this page was made

Generation history

Oct 31, 2026
Fact-check pass — raised 4 flags
Oct 31, 2026
Revision
Jun 8, 2026
Fact-check pass — raised 2 flags
Jun 8, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.